Identification of the copy number variant biomarkers for breast cancer subtypes
Molecular Genetics and Genomics
Breast cancer is a common and threatening malignant disease with multiple biological and clinical subtypes. It can be categorized into subtypes of luminal A, luminal B, Her2 positive, and basal-like. Copy number variants (CNVs) have been reported to be a potential and even better biomarker for cancer diagnosis than mRNA biomarkers, because it is considerably more stable and robust than gene expression. Thus, it is meaningful to detect CNVs of different cancers. To identify the CNV biomarker for breast cancer subtypes, we integrated the CNV data of more than 2000 samples from two large breast cancer databases, METABRIC and The Cancer Genome Atlas (TCGA). A Monte Carlo feature selection-based and incremental feature selection-based computational method was proposed and tested to identify the distinctive core CNVs in different breast cancer subtypes. We identified the CNV genes that may contribute to breast cancer tumorigenesis as well as built a set of quantitative distinctive rules for recognition of the breast cancer subtypes. The tenfold cross-validation Matthew’s correlation coefficient (MCC) on METABRIC training set and the independent test on TCGA dataset were 0.515 and 0.492, respectively. The CNVs of PGAP3, GRB7, MIR4728, PNMT, STARD3, TCAP and ERBB2 were important for the accurate diagnosis of breast cancer subtypes. The findings reported in this study may further uncover the difference between different breast cancer subtypes and improve the diagnosis accuracy.
|, , , ,|
|Molecular Genetics and Genomics|
|Organisation||Department of Medical Informatics|
Pan, X, Hu, X.H. (XiaoHua), Zhang, Y.-H. (Yu-Hang), Chen, L. (Lei), Zhu, L.C. (LiuCun), Wan, S.B. (ShiBao), … Cai, Y.-D. (Yu-Dong). (2018). Identification of the copy number variant biomarkers for breast cancer subtypes. Molecular Genetics and Genomics. doi:10.1007/s00438-018-1488-4